Release
📈 Stocks
CLS and ClearPoint Neuro Join $3M NIH-Funded Spinal Metastases Research
(4 days ago)
CLS and ClearPoint Neuro partner with Dartmouth Health on a $2.98 million NIH-funded study to validate MR-guided laser therapy for spinal metastases.